Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):209–215. doi: 10.1097/QAI.0b013e318289bb7e

Table 3.

Fat, muscle, bone, and hormone differences between functional groups.

Low Function (N=30) High function (N=48) Crude OR P value Adjusted* OR P value
Fat
 Relative fat mass (% body mass) 28.1 ± 1.6 24.7 ± 1.4 1.0 (0.9. 1.0) 0.14 0.9 (0.8, 1.0) 0.18
 Fat mass (kg) 21.2 ± 2.0 18.3 ± 1.6 1.0 (0.9, 1.0) 0.46 1.0 (0.9, 1.0) 0.54
 Trunk: limb fat 1.9 ± 0.2 2.1 ± 0.2 0.8 (0.5, 1.4) 0.47 0.9 (0.5, 1.6) 0.74
 Trunk: total fat 0.6 ± 0.02 0.6 ± 0.02 0.8 (0.4, 1.3) 0.36 0.9 (0.5, 1.7) 0.69
 Fat Index (kg/m2) 7.0 ± 0.7 6.2 ± 0.6 1.0 (0.9, 1.1) 0.55 1.0 (0.9, 1.1) 0.68
 %Trunk fat/% leg fat 1.9 ± 0.2 2.1 ± 0.2 0.8 (0.5, 1.4) 0.47 0.9 (0.5, 1.6) 0.74
Muscle
 Lean body mass (kg) 46.9 ± 1.7 51.6 ± 1.5 1.1 (1.0, 1.2) 0.023 1.1 (1.0, 1.2) 0.034
 Appendicular lean mass (kg) 20.6 ± 0.9 23.7 ± 0.7 1.3 (1.0, 1.4) 0.012 1.2 (1.1, 1.4) 0.017
 ASMI (kg/m2) 6.8 ± 0.2 7.8 ± 0.2 1.7 (1.1, 2.9) 0.012 1.8 (1.1, 2.9) 0.014
Bone
 Lumbar spine BMD (g/m2) 0.917 ± 0.026 1.007 ± 0.021 1.7 (1.1, 2.3) 0.023 2.1 (1.1, 4.0) 0.023
 Lumbar spine T-score −1.5 ± 0.2 −0.7 ± 0.2 1.7 (1.1, 2.3) 0.023 2.3 (1.1, 4.5) 0.022
 Femoral neck BMD (g/m2) 0.703 ± 0.021 0.758 ± 0.016 1.7 (1.0, 2.6) 0.051 2.0 (0.9, 4.3) 0.075
 Femoral neck T-score −1.6 ± 0.2 −1.2 ± 0.1 2.0 (0.98, 3.3) 0.057 2.3 (0.9, 6.3) 0.093
 Total hip BMD (g/m2) 0.812 ± 0.023 0.908 ± 0.019 2.0 (1.2, 3.3) 0.009 2.4 (1.1, 5.6) 0.032
 Total hip T-score −1.4 ± 0.2 −0.7 ± 0.1 2.5 (1.3, 5.9) 0.009 3.8 (1.1, 12.5) 0.028
Hormone
 IGF-1 (ng/mL) 99.0 ± 8.2 126.7 ± 6.6 5.0 (1.4, 20.0) 0.015 5.0 (1.4, 20.0) 0.015
 IGFBP-3 (μg/mL) 2.5 ± 0.2 3.5 ± 0.2 3.3 (1.6, 6.3) 0.001 3.3 (1.7, 9.9) 0.002
 25-OH vitamin D(ng/mL) 25.4 ± 2.3 29.5 ± 1.9 1.0 (0.99, 1.1) 0.11 1.0 (0.99, 1.1) 0.11

Values are presented as mean ± standard error. ASMI, appendicular skeletal muscle index. BMD, bone mineral density. IGF, insulin-like growth factor. IGFBP-insulin-like growth factor binding protein. Odds Ratio is for the incremental increase in odds of Low Function for an increase (↑) or decrease (↓) of one unit, unless otherwise indicated.

*

Adjusted for potential confounders:

Fat mass: CD4+ lymphocyte count < 350 cells/μL, current protease inhibitor, any use of zidovudine, didanosine or stavudine.

Lean mass: CD4+ lymphocyte count < 350 cells/μL and any use of zidovudine, didanosine or stavudine.

BMD: nadir CD4+ lymphocyte count, BMI (kg/m2), current tenofovir use, and tobacco use.

Hormone: CD4+ lymphocyte count < 350 cells/μL, fat mass ratio, and BMI (kg/m2),.

Odds per change of 0.1 units

Odds per change of 100 units